BRIEF-Axsome Therapeutics Announces Availability Of Symbravo® For The Acute Treatment Of Migraine

Reuters
10 Jun
BRIEF-Axsome <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Availability Of Symbravo® For The Acute Treatment Of Migraine

June 10 (Reuters) - Axsome Therapeutics Inc AXSM.O:

  • AXSOME THERAPEUTICS ANNOUNCES AVAILABILITY OF SYMBRAVO® (MELOXICAM AND RIZATRIPTAN) FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Source text: ID:nGNX3NWV0r

Further company coverage: AXSM.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10